Gene · 3714
Papers2,693
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,693
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrative Analysis of Gene Expression and Promoter Methylation to Differentiate High-Grade Serous Ovarian Cancer from Benign Tumors. | Biomedicines | 2025 | 40002854 | PubTator, text mining | PubMed |
| Notch signaling pathway in osteogenesis, bone development, metabolism, and diseases. | FASEB J | 2025 | 39985304 | PubTator, text mining | PubMed |
| STLBRF: an improved random forest algorithm based on standardized-threshold for feature screening of gene expression data. | Brief Funct Genomics | 2025 | 39736135 | PubTator, text mining | PubMed |
| Neutrophil extracellular traps activate Notch-γ-secretase signaling in hidradenitis suppurativa. | J Allergy Clin Immunol | 2025 | 39265876 | PubTator, text mining | PubMed |
| Spatially-resolved analyses of muscle invasive bladder cancer microenvironment unveil a distinct fibroblast cluster associated with prognosis. | Front Immunol | 2024 | 39759522 | PubTator, text mining | PubMed |
| Mll4 in skeletal muscle fibers maintains muscle stem cells. | Skelet Muscle | 2024 | 39710699 | PubTator, text mining | PubMed |
| Case Report: Exploring the clinical spectrum of LGMD R27: insights from a case study with homozygous pathogenic variant in the JAG2 gene. | Front Pediatr | 2024 | 39649397 | PubTator, text mining | PubMed |
| Mll4 in Skeletal Muscle Fiber Maintains Muscle Stem Cells by Regulating Notch Ligands. | Res Sq | 2024 | 39649158 | PubTator, text mining | PubMed |
| Chromatin accessibility: biological functions, molecular mechanisms and therapeutic application. | Signal Transduct Target Ther | 2024 | 39627201 | PubTator, text mining | PubMed |
| Differential Effects of Four Canonical Notch-Activating Ligands on c-Kit+ Cardiac Progenitor Cells. | Int J Mol Sci | 2024 | 39456964 | PubTator, text mining | PubMed |
| Dimension reduction, cell clustering, and cell-cell communication inference for single-cell transcriptomics with DcjComm. | Genome Biol | 2024 | 39252099 | PubTator, text mining | PubMed |
| Thr4 phosphorylation on RNA Pol II occurs at early transcription regulating 3'-end processing. | Sci Adv | 2024 | 39241064 | PubTator, text mining | PubMed |
| Convergent evolution of monocyte differentiation in adult skin instructs Langerhans cell identity. | Sci Immunol | 2024 | 39241057 | PubTator, text mining | PubMed |
| Three novel missense variants in two families with JAG2-associated limb-girdle muscular dystrophy. | Neuromuscul Disord | 2024 | 39121631 | PubTator, text mining | PubMed |
| Predicting regulatory mutations and their target genes by new computational integrative analysis: A study of follicular lymphoma. | Comput Biol Med | 2024 | 38901187 | PubTator, text mining | PubMed |
| β-tricalcium phosphate enhanced biomineralization of Cd2+ and Pb2+ by Sporosarcina ureilytica HJ1 and Sporosarcina pasteurii HJ2. | J Hazard Mater | 2024 | 38810579 | PubTator, text mining | PubMed |
| Disruption of Transmembrane Phosphatidylserine Asymmetry by HIV-1 Incorporated SERINC5 Is Not Responsible for Virus Restriction. | Biomolecules | 2024 | 38785977 | PubTator, text mining | PubMed |
| Interaction of Statherin-Derived Peptide with the Surface of Hydroxyapatite: Perspectives Based on Molecular Dynamics Simulations. | Caries Res | 2024 | 38763135 | PubTator, text mining | PubMed |
| Exome sequencing in genuine empty follicle syndrome: Novel candidate genes. | Eur J Obstet Gynecol Reprod Biol | 2024 | 38691974 | PubTator, text mining | PubMed |
| Jagged2 targeting in lung cancer activates anti-tumor immunity via Notch-induced functional reprogramming of tumor-associated macrophages. | Immunity | 2024 | 38636522 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3714/papers?page=4